ARTICLE | Clinical News
Cell Pathways regulatory update
February 28, 1994 8:00 AM UTC
Cell Pathways' FGN-1, a small molecule from a group of compounds that have anti-cancer effects in tissue culture and in animals, received orphan drug designation from the FDA to treat the inherited fo...